Emblem Corp EMMBF

RE:EMC

[canaken1]

Buyers now are smart investors. With the sp so low - smart moves for growth is approaching . With Health Canada's approval to carry out research and development activities! As per May 14th. NR, ie  one month ago, Canntab delivered the development & processing equipment to EMC's Paris location and began making the first batch of the oral sustained release tablet formulations of cannabinoids (Products). Products to be inhouse and third party tested for stability study confirming the Product provides "extended release" . This will be followed by people trial with blood sampling over 12 hour periods. Results analyzed for regulatory approval. The smart people know , they have had lots of time to do all this before getting to Paris, why else would it be Patent-Pending. 

On Oct.3rd.,2017 EMC signed a Licensing agreement with Canntab for the same Patent-Pending equipment which has had a few months for them to carry-out any necessary modifications and improvement prior to shipping to Paris and if all goes well Emblem may be using the equipment in their production shifts for next year . Longs may be given a good surprise before Christmas.glta